Institutional investors purchased a net $1.3 million shares of ABMD during the quarter ended June 2015 and now own 92.33% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 400.00 shares of Abiomed Inc
BLACKROCK INVESTMENT MANAGEMENT ... Bought 296.00 shares of Abiomed Inc
STATE STREET GLOBAL ADVISORS LTD... Bought 69.00 shares of Abiomed Inc